Correlation Between Xencor and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Xencor and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xencor and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xencor Inc and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Xencor and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xencor with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xencor and Syndax Pharmaceuticals.
Diversification Opportunities for Xencor and Syndax Pharmaceuticals
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Xencor and Syndax is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Xencor Inc and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Xencor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xencor Inc are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Xencor i.e., Xencor and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Xencor and Syndax Pharmaceuticals
Given the investment horizon of 90 days Xencor Inc is expected to under-perform the Syndax Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Xencor Inc is 1.05 times less risky than Syndax Pharmaceuticals. The stock trades about -0.07 of its potential returns per unit of risk. The Syndax Pharmaceuticals is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 1,930 in Syndax Pharmaceuticals on November 28, 2024 and sell it today you would lose (406.00) from holding Syndax Pharmaceuticals or give up 21.04% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Xencor Inc vs. Syndax Pharmaceuticals
Performance |
Timeline |
Xencor Inc |
Syndax Pharmaceuticals |
Xencor and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Xencor and Syndax Pharmaceuticals
The main advantage of trading using opposite Xencor and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xencor position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.Xencor vs. Edgewise Therapeutics | Xencor vs. Keros Therapeutics | Xencor vs. Monte Rosa Therapeutics | Xencor vs. Mineralys Therapeutics, Common |
Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stocks Directory Find actively traded stocks across global markets |